Following Healthy Pregnancy by Nuclear Magnetic Resonance (NMR) Metabolic Profiling of Human Urine

abstract

In this work, untargeted NMR metabonomics was employed to evaluate the effects of pregnancy on the metabolite composition of maternal urine, thus establishing a control excretory trajectory for healthy pregnancies. Urine was collected for independent groups of healthy nonpregnant and pregnant women (in first, second, third trimesters) and multivariate analysis performed on the corresponding NMR spectra. Models were validated through Monte Carlo Cross Validation and permutation tests and metabolite correlations measured through Statistical Total Correlation Spectroscopy. The levels of 21 metabolites were found to change significantly throughout pregnancy, with variations observed for the first time to our knowledge for choline, creatinine, 4-deoxyerythronic acid, 4-deoxythreonic acid, furoylglycine, guanidoacetate, 3-hydroxybutyrate, and lactate. Results confirmed increased aminoaciduria across pregnancy and suggested (a) a particular involvement of isoleucine and threonine in lipid oxidation/ketone body synthesis, (b) a relation of excreted choline, taurine, and guanidoacetate to methionine metabolism and urea cycle regulation, and (c) a possible relationship of furoylglycine and creatinine to pregnancy, based on a tandem study of nonfasting confounding effects. Results demonstrate the usefulness of untargeted metabonomics in finding biomarker metabolic signatures for healthy pregnancies, against which disease-related deviations may be confronted in future studies, as a base for improved diagnostics and prediction.

keywords

TRIMESTER AMNIOTIC-FLUID; GESTATIONAL-AGE; PRENATAL DISORDERS; DISEASE DIAGNOSIS; MATERNAL URINE; ORGANIC-ACIDS; BIOMARKERS; 2ND; PREECLAMPSIA; SPECTROSCOPY

subject category

Biochemistry & Molecular Biology

authors

Diaz, SO; Barros, AS; Goodfellow, BJ; Duarte, IF; Carreira, IM; Galhano, E; Pita, C; Almeida, MD; Gil, AM

our authors

acknowledgements

Funding is acknowledged from the European Regional Development Fund (FEDER) through the Competitive Factors Thematic Operational Programme (COMPETE) and from the Foundation for Science and Technology (FCT), Portugal, under the projects Pest-C/CTM/LA0011/2011, PTDC/QUI/66523/2006, and grant SFRH/BD/64159/2009. The authors are grateful to the Portuguese National NMR Network (RNRMN), supported with FCT funds, and to M. Spraul, Bruker BioSpin, Germany, for providing access to spectral databases.

Share this project:

Related Publications

We use cookies for marketing activities and to offer you a better experience. By clicking “Accept Cookies” you agree with our cookie policy. Read about how we use cookies by clicking "Privacy and Cookie Policy".